Alpine Associates Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Alpine Associates Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-762,900	Closed	-$47.4M	–	53
2023 Q4	$47.4M	Buy	+762,900	New	+$19M	2.43%	15

Alpine Associates Management's RYZB Position: Q1 2024 in Review

Alpine Associates Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 762,900 shares — an estimated $47.4M sold.

Alpine Associates Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $47.4M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Alpine Associates Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Alpine Associates Management sold 762,900 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $47.4M.
Alpine Associates Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Alpine Associates Management's RayzeBio, Inc. Common Stock position peaked at $47.4M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Alpine Associates Management's 13F filing for Q1 2024, filed 9 May 2024.